Cassava Stock Today

SAVA -  USA Stock  

USD 46.56  0.17  0.37%

Cassava Sciences is trading at 46.56 as of the 22nd of October 2021, a 0.37 percent increase since the beginning of the trading day. The stock's open price was 46.39. Cassava Sciences has more than 69 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Cassava Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of August 2021 and ending today, the 22nd of October 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Over 69
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 40.01 M outstanding shares of which 3.78 M shares are at this time shorted by private and institutional investors with about 2.64 trading days to cover. More on Cassava Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Cassava Sciences Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Cassava Sciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cassava Sciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cassava Sciences generated a negative expected return over the last 90 days
Cassava Sciences has high historical volatility and very poor performance
Cassava Sciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (8.71 M) with loss before overhead, payroll, taxes, and interest of (3.05 M).
Cassava Sciences currently holds about 282.19 M in cash with (6.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.05.
Latest headline from www.entrepreneur.com: Cassava Sciences, Inc. Outpaces Stock Market Gains What You Should Know - Entrepreneur
Legal NameCassava Sciences
ChairmanRemi Barbier  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Cassava Sciences' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cassava Sciences (SAVA) is traded on NASDAQ Exchange in USA and employs 11 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cassava Sciences's market, we take the total number of its shares issued and multiply it by Cassava Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Cassava Sciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 40.01 M outstanding shares of which 3.78 M shares are at this time shorted by private and institutional investors with about 2.64 trading days to cover. Cassava Sciences currently holds about 282.19 M in cash with (6.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.05.
Check Cassava Sciences Probability Of Bankruptcy
Ownership
Cassava Sciences retains a total of 40.01 Million outstanding shares. Cassava Sciences shows 6.49 percent if its outstanding shares held by insiders and 6.49 percent owned by other corporate entities . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Cassava Ownership Details

Cassava Stock Price Odds Analysis

What are Cassava Sciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Cassava Sciences jumping above the current price in 90 days from now is about 83.33%. The Cassava Sciences probability density function shows the probability of Cassava Sciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3525. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cassava Sciences will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cassava Sciences is significantly underperforming DOW.
 Odds Down 46.56HorizonTargetOdds Up 46.56 
16.63%90 days
 46.56 
83.33%
Based on a normal probability distribution, the odds of Cassava Sciences to move above the current price in 90 days from now is about 83.33 (This Cassava Sciences probability density function shows the probability of Cassava Stock to fall within a particular range of prices over 90 days) .

Cassava Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Cassava Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cassava Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cassava Sciences' value.
InstituionSecurity TypeTotal SharesValue
Golden Green IncCommon Shares33.5 K2.1 M
Ivc Wealth Advisors LlcCommon Shares9.9 K613 K
View Cassava Sciences Diagnostics

Cassava Sciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cassava Sciences market risk premium is the additional return an investor will receive from holding Cassava Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cassava Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cassava Sciences' alpha and beta are two of the key measurements used to evaluate Cassava Sciences' performance over the market, the standard measures of volatility play an important role as well.

Cassava Stock Against Markets

Picking the right benchmark for Cassava Sciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cassava Sciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cassava Sciences is critical whether you are bullish or bearish towards Cassava Sciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cassava Sciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Cassava Sciences Corporate Directors

Cassava Sciences corporate directors refer to members of a Cassava Sciences board of directors. The board of directors generally takes responsibility for the Cassava Sciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cassava Sciences' board members must vote for the resolution. The Cassava Sciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Saira Ramasastry - Independent DirectorProfile
Nadav Friedmann - Chief Medical and Operating Officer, DirectorProfile
Michael Donnell - Independent DirectorProfile
Patrick Scannon - Independent DirectorProfile
Additionally, take a look at World Market Map. Note that the Cassava Sciences information on this page should be used as a complementary analysis to other Cassava Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Cassava Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.